Drug Trial Radar · NCT07661056
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Jun 26, 2026
Primary completion
Jan 2028
Study completion Feb 2028
Sponsor
- Lead sponsor
- Biohaven Therapeutics Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 22, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of BHV-1300 in adult participants with Graves' disease who are actively hyperthyroid
Conditions
- Graves Disease
Interventions
BHV-1300Drug
delivered subcutaneously via autoinjector
PlaceboDrug
delivered subcutaneously via autoinjector
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants on BHV-1300 vs placebo who are not on an antithyroid drug and with normal thyroid function (total T3, free T4 (FT4), & TSH within normal limits) at Week 26.Time frame: Week 26
Locations
63 sites in 3 countries. Site status is shown where the registry gives one.
Site-044
Tucson, Arizona · Recruiting
Site-032
Burbank, California · Recruiting
Site-062
Huntington Beach, California · Recruiting
Site-056
La Jolla, California · Recruiting
Site-048
Oakland, California · Recruiting
Site-006
San Diego, California · Recruiting
Site-078
South Gate, California · Recruiting
Site-067
Walnut Creek, California · Recruiting
Site-035
Washington D.C., District of Columbia · Recruiting
Site-052
Doral, Florida · Recruiting
Site-066
Fort Myers, Florida · Recruiting
Site-019
Hialeah, Florida · Recruiting
Site-027
Hollywood, Florida · Recruiting
Site-061
Miami, Florida · Recruiting
Site-059
Palm Beach Gardens, Florida · Recruiting
Site-074
Tampa, Florida · Recruiting
Site-029
Atlanta, Georgia · Recruiting
Site-053
Fayetteville, Georgia · Recruiting
Site-031
Champaign, Illinois · Recruiting
Site-068
Oak Brook, Illinois · Recruiting
Site-080
Springfield, Illinois · Recruiting
Site-025
Lenexa, Kansas · Recruiting
Site-070
Baton Rouge, Louisiana · Recruiting
Site-046
Farmington Hills, Michigan · Recruiting
Site-004
Kansas City, Missouri · Recruiting
Site-015
St Louis, Missouri · Recruiting
Site-072
Las Vegas, Nevada · Recruiting
Site-047
Albuquerque, New Mexico · Recruiting
Site-077
Orchard Park, New York · Recruiting
Site-038
Asheville, North Carolina · Recruiting
Site-011
Greenville, North Carolina · Recruiting
Site-063
Morehead City, North Carolina · Recruiting
Site-064
Morehead City, North Carolina · Recruiting
Site-039
Raleigh, North Carolina · Recruiting
Site-033
Statesville, North Carolina · Recruiting
Site-045
Wilmington, North Carolina · Recruiting
Site-008
Canton, Ohio · Recruiting
Site-021
Cincinnati, Ohio · Recruiting
Site-037
Norman, Oklahoma · Recruiting
Site - 012
Philadelphia, Pennsylvania · Recruiting
Showing 40 of 63 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.